(Total Views: 328)
Posted On: 10/10/2020 3:09:13 PM
Post# of 36509
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Listing should be done asap, if 1-2 investors are lined up and we meet IPO/Nasdaq requirements get it done. The current momentum will attract real investors while Covid interest is still "hot" . Each positive PR will ignite excitement and hopefully increase volume/pps. Don't forget it's a race to the finish line and 300+ potential vaccines/therapies competing for market share.
Here is a reminder of approx 200 potential players , some already well rewarded in pps/funding.
https://www.who.int/publications/m/item/draft...e-vaccines
Here is a reminder of approx 200 potential players , some already well rewarded in pps/funding.
https://www.who.int/publications/m/item/draft...e-vaccines
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)